-
1.
公开(公告)号:KR1020090037498A
公开(公告)日:2009-04-15
申请号:KR1020097004570
申请日:2007-08-03
Applicant: 포항공과대학교 산학협력단
CPC classification number: A61K38/1709 , C07K14/4702 , C12N9/20 , C12Y301/04004 , G01N33/5011 , G01N2333/9121 , G01N2333/916
Abstract: A method for controlling the activity of mTOR(mammalian target-of-rapamycin) with the interaction of phospholipase D(PLD) and raptor is provided to cure metabolic diseases related with mTOR by controlling mTOR through the control of the PLD activity. A method for controlling the activity of mTOR(mammalian target-of-rapamycin) is to suppress PLD2 through raptor and mTOR complex(PLD/raptor/mTOR complex) by suppressing the interaction of PLD2 and raptor. Suppressing the formation of the PLD/raptor/mTOR complex is performed by inactivating a raptor binding domain of PLD2 or a PLD2 binding domain of raptor.
Abstract translation: 提供了通过控制mTOR通过控制PLD活性来控制mTOR(哺乳动物雷帕霉素靶)与磷脂酶D(PLD)和猛禽相互作用的活性的方法,以治疗与mTOR相关的代谢疾病。 用于控制mTOR(哺乳动物雷帕霉素靶)活性的方法是通过抑制PLD2和猛禽的相互作用来抑制PLD2通过猛禽和mTOR复合物(PLD / raptor / mTOR复合物)。 抑制PLD / raptor / mTOR复合物的形成是通过灭活猛禽的PLD2或PLD2结合结构域的猛禽结合结构域来实现的。